摘要
噻吗洛尔 (timolol)是非选择性 β 受体阻断剂 ,在心血管内科用于治疗急性心肌梗死 ,早期应用可改善患者的并发症和生存率 ,长期使用能降低心梗后的再梗死率和死亡率。
Timolol is a non selective β blocker for treatment of acute myocardial infarction(AMI).The complications and survival rate of patients with AMI may be improved by its early use.The rate of re infarction and mortality may be significantly reduced by long term uses.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2001年第9期665-667,共3页
Chinese Journal of New Drugs